The use of chimeric antigen receptor (CAR) T cells is one of the most promising advances in cancer immunotherapy. BioCytoceuticals, with deep roots in rich industrial and academic experience, has developed systematic approaches to provide our clients with gene package, plasmid development, and T cell production services.
Production and testing of CD123-specific CARs with chimeric scFvs.
BioCytoceuticals leads the industry in cellular therapy with commitment to provide the most appropriate solutions to address the needs of our clients. Our expert team of scientists applies comprehensive methods and most detail-oriented scrutiny to ensure only top-tier outcome is submitted.
If you have any special enquiries regarding our CAR-T GMP Production service, please do not hesitate to contact us. Our highly professional technical supporting staffs will make sure your requests are faithfully received. We are looking forward to earning your business.
Inquiry
